Information regarding the total number of voting rights and total number of shares of the Company as of April 30, 2025
(Article 223-16 of the General Regulations of the Autorité des Marchés Financiers)
Market : NYSE Euronext Paris
ISIN Code: FR 0010417345
Date | Total number of shares | Total number of voting rights |
| 04/30/2025 | 136,948,872 | Total gross of voting rights: 136,948,872 |
Total net* of voting rights: 136,762,549 |
* Net total = total number of voting rights attached to shares – shares without voting rights
| Last Trade: | US$8.47 |
| Daily Change: | -0.31 -3.48 |
| Daily Volume: | 59,709 |
| Market Cap: | US$173.700M |
January 08, 2025 December 11, 2024 | |
Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...
CLICK TO LEARN MORE
Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...
CLICK TO LEARN MORE
